which is safer tirzepatide or semaglutide vs. Semaglutide: What You Should Know New report reveals illegal ingredients

Efficacy and safety of adding once-weekly dulaglutide to basal insulin for inadequately controlled type 2 diabetes in Chinese patients (AWARD-CHN3): A randomized, double-blind, placebo-controlled, phase III trial

885 Fall, C

The most common side effects include nausea, vomiting, diarrhoea, decreased appetite, constipation, stomach pain, and indigestion, and these tend to be most noticeable during the initial weeks of treatment or shortly after a dose increase, typically easing as the body adjusts

When to Consult Your Healthcare Provider While a runny nose is generally a minor inconvenience, your safety is the top priority